Efficacy And Tolerability Of EPs 7630 In Patients (aged 6-18 Years Old) With Acute Bronchitis

Effect Increase
Trial Design Double blind
Trial Length 1-7 Days
Number of Subjects 400
Gender Both Genders
Age Range 7-12, 13-17
Body Types Average
Notes for this study:
Supplementation of 10-30mg of EPs7630 thrice daily in youth and adolescents with acute bronchitis over a week was able to reduce symptoms as assessed by the BSS in a dose-dependent manner (although all doses were more effective than placebo).

Efficacy And Tolerability Of EPs 7630 In Children And Adolescents With Acute Bronchitis - A Randomized, Double-blind, Placebo-controlled Multicenter Trial With A Herbal Drug Preparation From Pelargonium Sidoides Roots

Effect Increase
Trial Design Double blind
Trial Length 1-7 Days
Number of Subjects 200
Gender Both Genders
Age Range 1-6, 7-12, 13-17
Body Types Average
Notes for this study:
The standard doses of EPs7630 drops to children under six (10 drops thrice daily), between six and twelve (20 drops) and older (30 drops) over the course of a week to treat acute bronchitis was effective in reducing symptoms of bronchitis and improving overall well being relative to placebo.

Treatment Of Acute Bronchitis In Adults With A Pelargonium Sidoides Preparation (EPs 7630): A Randomized, Double-blind, Placebo-controlled Trial

Effect Increase
Trial Design Double blind
Trial Length 1-7 Days
Number of Subjects 107
Gender Both Genders
Age Range 18-29, 30-44, 45-64
Body Types Average
Notes for this study:
30 drops (4.5mL) of EPs7630 thrice daily for a week in adults with acute bronchitis was associated with significant reductions in symptoms as assessed by the BSS rating scale. There was also a greater change of a 5 point reduction in the treatment group (90.6%) rather than placebo (51.7%) and reported rapid recovery (90.6% relative to 41.7%); there were significantly more remissions of cough (31.3%), rhonchi (91%)

Efficacy And Tolerability Of EPs 7630 Tablets In Patients With Acute Bronchitis: A Randomised, Double-blind, Placebo-controlled Dose-finding Study With A Herbal Drug Preparation From Pelargonium Sidoides

Effect Increase
Trial Design Double blind
Trial Length 1-7 Days
Number of Subjects 404
Gender Both Genders
Age Range 30-44, 45-64
Body Types Overweight
Notes for this study:
Patients with acute bronchitis administered EPs7630 in capsules ranging from 10mg thrice daily to 30mg thrice daily (or placebo) over the course of one week noted that 20mg and 30mg groups were equally effective over placebo while 10mg was sometimes effective over placebo but unreliably so.